Hepatitis Foundation International   photo
The Good We Do Living with Hepatitis News and Research Support Education Donate Contact Us Home

 

Heplink Online Learning Center Subscribe to Our Newsletter E-Store

Clinical Trials Resource Center

About Research  |   Trials  |   NIH Trials  |   Email Notifications  |   FDA Approvals  |   Research Centers
Research Headlines  |   NMT Results  |   Bookstore

Therapeutic Areas: Cardiology/Vascular Diseases

Atrial Flutter Clinical Trials

A listing of Atrial Flutter medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alaska

Anchorage Alaska 99508

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Arizona

Phoenix Arizona 85018

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Phoenix Arizona 85004

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

California

East Palo Alto California 94303

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

La Jolla California 92037

A clinical research study of Amigo™ Robotic Catheter Manipulation and Manual Catheter Manipulation for the treatment of Atrial Fibrillation or Atrial Flutter

Loma Linda California 92357

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Pasadena California 91105

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Stanford California 94305

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Colorado

Aurora Colorado 80045

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Denver Colorado 80120

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Florida

University of South Florida - South Tampa Center for Advanced Healthcare
Tampa Florida 33606

GENETIC-AF: A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients with Heart Failure

Miami Florida 33136

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Tampa Florida 33606

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Georgia

Athens Georgia 30606

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Atlanta Georgia 30322

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Augusta Georgia 30912

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Lawrenceville Georgia 30046

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Rome Georgia 30165

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Illinois

Gurnee Illinois 60031

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Oakbrook Terrace Illinois 60181

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Indiana

Hammond Indiana 46320

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Iowa

Iowa City Iowa 52242

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Louisiana

New Orleans Louisiana 70121

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Michigan

Ypsilanti Michigan 48197

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Minnesota

Minneapolis Minnesota 55417

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

St. Paul Minnesota 55102

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Missouri

St. Louis Missouri 63110

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Nebraska

Lincoln Nebraska 68506

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

New Jersey

Elmer New Jersey 08318

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

New York

Albany New York 12205

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

North Carolina

Durham North Carolina 27705

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Greensboro North Carolina 27401

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Ohio

Akron Ohio 44304

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Cincinnati Ohio 45219

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Cleveland Ohio 44106

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Columbus Ohio 43210

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Oklahoma

Oklahoma City Oklahoma 73120

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Oregon

Portland Oregon 97201

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Pennsylvania

Hershey Pennsylvania 17033

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Lancaster Pennsylvania 17603

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Philadelphia Pennsylvania 19104

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Pittsburgh Pennsylvania 15212

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Tennessee

Germantown Tennessee 38138

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Jackson Tennessee 38305

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Nashville Tennessee 37232

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Texas

Austin Texas 78705

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Dallas Texas 75230

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Utah

Salt Lake City Utah 84132

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Virginia

Charlottesville Virginia 22908

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Falls Church Virginia 22042

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

the good we do  |  living with hepatitis  |  news & research  |  support donate  |  contact us  |  site map  |   home

nnac  |  online learning center  |  subscribe to our newsletter   |   disclaimer  |  privacy

 

 

Hepatitis Foundation International
(800) 891-0707
HFI@comcast.net

©2003. All rights reserved.